Samsung Bioepis Co.
Samsung Bioepis Co., Ltd.
76, Songdogyoyuk-ro, Yeonsu-gu, Incheon, Republic of Korea
Phone: +82-32-728-0114Website: https://www.samsungbioepis.com/en/index.doCareers: www.samsungbioepis.com/en/careers...
Latest news
- FDA Approves Opuviz (aflibercept-yszy), an Interchangeable Biosimilar to Eylea
20 May 2024 - Samsung Bioepis and Organon Announce FDA Approval of Citrate-Free High-Concentration Humira® Biosimilar Hadlima™ (adalimumab-bwwd)
17 August 2022 - FDA Approves Byooviz (ranibizumab-nuna), a Biosimilar to Lucentis
20 September 2021 - Samsung Bioepis and Biogen Announce FDA Filing Acceptance of SB11, A Proposed Biosimilar Referencing Lucentis® (ranibizumab)
18 November 2020 - Samsung Bioepis Announces One-Year Results from Phase 3 Study of SB11, a Proposed Biosimilar to Lucentis® (ranibizumab)
11 November 2020 - Samsung Bioepis Announces 24-week Interim Results from a Phase 3 Trial of SB11, Proposed Ranibizumab Biosimilar
18 May 2020 - FDA Approves Hadlima (adalimumab-bwwd), a Biosimilar to Humira
23 July 2019 - FDA Approves Eticovo (etanercept-ykro), a Biosimilar to Enbrel
27 April 2019 - FDA Approves Ontruzant (trastuzumab-dttb), a Biosimilar to Herceptin
21 January 2019 - Samsung Bioepis’ SB3 Trastuzumab Biosimilar Candidate Accepted for Review by the US Food and Drug Administration
20 December 2017
Drugs Associated with Samsung Bioepis Co., Ltd.
Samsung Bioepis Co., Ltd. manufactures, markets and/or distributes more than 5 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
Brand/Generic Name | Reviews | Rating |
---|---|---|
Byooviz
Generic name: ranibizumab Drug class: anti-angiogenic ophthalmic agents |
||
Eticovo
Generic name: etanercept Drug class: antirheumatics, TNF alfa inhibitors |
||
Hadlima
Generic name: adalimumab Drug class: TNF alfa inhibitors |
||
Ontruzant
Generic name: trastuzumab Drug class: HER2 inhibitors |
||
Renflexis
Generic name: infliximab Drug class: TNF alfa inhibitors |
8 reviews | 7.1 / 10 |
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). |